These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 5571715

  • 1. [L-dopa effect in Parkinson's syndrome].
    Römer F, Bettag W, Bock WJ.
    Z Allgemeinmed; 1971 Feb 28; 47(6):281-3. PubMed ID: 5571715
    [No Abstract] [Full Text] [Related]

  • 2. [New methods for measurement of the tremor and rigidity in patients with Parkinson's disease treated with L-Dopa].
    Paci A, Freddi A, Barba C.
    Riv Neurol; 1973 Feb 28; 43(1):15-39. PubMed ID: 4698011
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Quantitative measurements of L-dopa therapy in Parkinson's disease.
    Webster DD.
    Trans Am Neurol Assoc; 1969 Feb 28; 94():348-50. PubMed ID: 5374483
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of Parkinson's syndrome with L-dopa].
    Ljung O.
    Lakartidningen; 1972 Jun 07; 69(24):2940-4. PubMed ID: 5037135
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Failures of L-dopa.
    Paulson GW.
    Ohio State Med J; 1973 Dec 07; 69(12):896-8. PubMed ID: 4769406
    [No Abstract] [Full Text] [Related]

  • 13. [Silent period in patients with Parkinson's disease treated with L-Dopa].
    Palao Sánchez A.
    Arch Neurobiol (Madr); 1973 Dec 07; 36(1):47-56. PubMed ID: 4706780
    [No Abstract] [Full Text] [Related]

  • 14. [Personal experience in the treatment of Parkinson's disease with L-Dopa].
    Figuerido JA, De la Herrán J.
    Rev Clin Esp; 1970 Dec 31; 119(6):555-62. PubMed ID: 5509794
    [No Abstract] [Full Text] [Related]

  • 15. The role of a dihydromorphanthridine derivative in Parkinson's patients treated with L-dopa. A preliminary report.
    Wycis HT.
    Confin Neurol; 1972 Dec 31; 34(1):130-5. PubMed ID: 5084387
    [No Abstract] [Full Text] [Related]

  • 16. [Management of Parkinson's syndrome using levadopa. Results of a long-term study].
    Wälzholz U.
    Dtsch Med Wochenschr; 1972 Apr 28; 97(17):686 passim. PubMed ID: 4554502
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of L-dopa treatment on the speech of patients with Parkinson's disease.
    Audelman JU, Hoel RL, Lassman FM.
    Neurology; 1970 Apr 28; 20(4):410-1. PubMed ID: 5535064
    [No Abstract] [Full Text] [Related]

  • 20. [Action of L-dopa in Parkinson's syndrome].
    Ucar S, Eiras J.
    Rev Clin Esp; 1971 Feb 15; 120(3):257-62. PubMed ID: 5568474
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.